Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (171-180 of 487) with videos related to

Pageof 49
Sort By:
Current Problems in Cancer|October 28, 2021
<sup>18</sup>F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastasesKalevi Kairemo, Jason Roszik, Pete Anderson, et al.
Molecular Cancer Therapeutics|August 24, 2012
Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonistVivek Subbiah, Robert E Brown, Jamie Buryanek, et al.
Trends in Cancer|July 5, 2023
Pearls and pitfalls of ChatGPT in medical oncologyJacob Blum, Arjun K Menta, Xiyu Zhao, et al.
JCO Precision Oncology|August 28, 2018
Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse MalignanciesShumei Kato, Jeffrey S Ross, Laurie Gay, et al.
Nature Reviews. Clinical Oncology|October 6, 2021
Author Correction: EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|January 24, 2020
Cannabidiol (CBD) Oil, Cancer, and Symptom Management: A Google Trends Analysis of Public InterestSanthosshi Narayanan, Felippe Lazar Neto, Kimberson Tanco, et al.
Journal of Hematology & Oncology|October 26, 2022
Drugging KRAS: current perspectives and state-of-art reviewKaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Journal of Comparative Effectiveness Research|January 11, 2024
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchersKristian Thorlund, Stephen Duffield, Sanjay Popat, et al.
JCO Precision Oncology|October 26, 2019
Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With <i>AKT1_E17K</i> MutationBranko Cuglievan, Vivek Subbiah, Huamin Wang, et al.
Oncoscience|September 2, 2015
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patientsVivek Subbiah, Manojkumar Bupathi, Shumei Kato, et al.
Pageof 49

Showing results (171-180 of 487) with videos related to

Sort By:
Pageof 49
Current Problems in Cancer|October 28, 2021
<sup>18</sup>F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastasesKalevi Kairemo, Jason Roszik, Pete Anderson, et al.
Molecular Cancer Therapeutics|August 24, 2012
Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonistVivek Subbiah, Robert E Brown, Jamie Buryanek, et al.
Trends in Cancer|July 5, 2023
Pearls and pitfalls of ChatGPT in medical oncologyJacob Blum, Arjun K Menta, Xiyu Zhao, et al.
JCO Precision Oncology|August 28, 2018
Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse MalignanciesShumei Kato, Jeffrey S Ross, Laurie Gay, et al.
Nature Reviews. Clinical Oncology|October 6, 2021
Author Correction: EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|January 24, 2020
Cannabidiol (CBD) Oil, Cancer, and Symptom Management: A Google Trends Analysis of Public InterestSanthosshi Narayanan, Felippe Lazar Neto, Kimberson Tanco, et al.
Journal of Hematology & Oncology|October 26, 2022
Drugging KRAS: current perspectives and state-of-art reviewKaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Journal of Comparative Effectiveness Research|January 11, 2024
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchersKristian Thorlund, Stephen Duffield, Sanjay Popat, et al.
JCO Precision Oncology|October 26, 2019
Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With <i>AKT1_E17K</i> MutationBranko Cuglievan, Vivek Subbiah, Huamin Wang, et al.
Oncoscience|September 2, 2015
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patientsVivek Subbiah, Manojkumar Bupathi, Shumei Kato, et al.
Pageof 49